A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
AstraZeneca
Alpha Biopharma (Jiangsu) Co., Ltd.
Spanish Lung Cancer Group
University of Utah
Daiichi Sankyo
Heat Biologics
Celgene
Daiichi Sankyo
Sichuan Cancer Hospital and Research Institute
Sun Yat-sen University
GlaxoSmithKline
Groupe Francais De Pneumo-Cancerologie
Groupe Francais De Pneumo-Cancerologie
Chroma Therapeutics
Sanofi
Sanofi
Astellas Pharma Inc
Hellenic Oncology Research Group